N. Ananyeva

发表

Effect of factor VIII on tissue factor-initiated spatial clot growth

F. Ataullakhanov, M. Ovanesov, E. Saenko, 2003, Thrombosis and Haemostasis.

Molecular defects in coagulation Factor VIII and their impact on Factor VIII function

C. Hauser, D. Josić, S. Pipe, 2002, Vox sanguinis.

Identification of coagulation factor VIII A2 domain residues forming the binding epitope for low-density lipoprotein receptor-related protein.

D. Strickland, K. Radtke, Dudley K Strickland, 2006, Biochemistry.

Interaction of coagulation factor VIII with members of the low-density lipoprotein receptor family follows common mechanism and involves consensus residues within the A2 binding site 484–509

K. Radtke, M. Shima, I. Pechik, 2008, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

The binding sites for the very low density lipoprotein receptor and low-density lipoprotein receptor-related protein are shared within coagulation factor VIII

D. Strickland, M. Shima, E. Saenko, 2008, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Localization of the low-density lipoprotein receptor-related protein regions involved in binding to the A2 domain of coagulation factor VIII

I. Mikhailenko, D. Strickland, M. Shima, 2007, Thrombosis and Haemostasis.

Coagulation pathways in atherothrombosis.

J. Griffin, E. Saenko, A. Khrenov, 2002, Trends in cardiovascular medicine.

Hemophilia A--from basic science to clinical practice.

C. Hauser, E. Saenko, J. Klinge, 2002, Seminars in thrombosis and hemostasis.

Initiation and propagation of coagulation from tissue factor‐bearing cell monolayers to plasma: initiator cells do not regulate spatial growth rate *

F. Ataullakhanov, M. Panteleev, M. Ovanesov, 2005, Journal of thrombosis and haemostasis : JTH.

Factor VIIIa regulates substrate delivery to the intrinsic factor X‐activating complex

F. Ataullakhanov, M. Panteleev, E. Saenko, 2006, The FEBS journal.

Kinetics of Factor X activation by the membrane-bound complex of Factor IXa and Factor VIIIa.

F. Ataullakhanov, M. Panteleev, E. Saenko, 2004, The Biochemical journal.

Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque.

M. Shima, E. Saenko, N. Ananyeva, 2002, Blood.

Laboratory tests for coagulation system monitoring in a patient with β-thalassemia

F. Ataullakhanov, I. Gribkova, E. B. Orel, 2014, International Journal of Hematology.

Laboratory tests for coagulation system monitoring in a patient with b-thalassemia Elena A. SereginaOlga F. NikulinaNina V. TsvetaevaMaya N. Rodionova • Irina V. GribkovaElena B. OrelAnastasiya P. ZapariyAnatoliy V. Erasov • Anna N. BalandinaNatalya M. AnanyevaFazoil I. Ataullakhanov

F. Ataullakhanov, I. Gribkova, E. B. Orel, 2014 .

Two subpopulations of thrombin‐activated platelets differ in their binding of the components of the intrinsic factor X‐activating complex

F. Ataullakhanov, E. Saenko, N. Greco, 2005, Journal of thrombosis and haemostasis : JTH.

Development and applications of surface plasmon resonance-based von Willebrand factor-collagen binding assay.

D. Josić, M. Shima, A. Sarafanov, 2002, Analytical biochemistry.

Role of the B domain in proteolytic inactivation of activated coagulation factor VIII by activated protein C and activated factor X

E. Saenko, A. Khrenov, N. Ananyeva, 2006, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

The future of recombinant coagulation factors

S. Pipe, M. Shima, E. Saenko, 2003, Journal of thrombosis and haemostasis : JTH.

Identification and characterization of three cDNAs that encode putative novel hyaluronan-binding proteins, including an endothelial cell-specific hyaluronan receptor.

G. Liau, N. Ananyeva, G. Hastings, 1999, The American journal of pathology.

Inhibitors in hemophilia A: advances in elucidation of inhibitory mechanisms and in inhibitor management with bypassing agents.

M. Shima, N. Jain, Timothy K. Lee, 2009, Seminars in thrombosis and hemostasis.

Treating haemophilia A with recombinant blood factors: a comparison

A. Sarafanov, E. Saenko, F. Darr, 2004, Expert opinion on pharmacotherapy.

Catabolism of the coagulation factor VIII: can we prolong lifetime of f VIII in circulation?

M. Shima, E. Saenko, N. Ananyeva, 2001, Trends in cardiovascular medicine.

Low Density Lipoproteins Interact With Acidic Fibroblast Growth Factor and Modify Its Function

C. Haudenschild, E. Saenko, N. Ananyeva, 2003, Arteriosclerosis, thrombosis, and vascular biology.

Comparison of the properties of phospholipid surfaces formed on HPA and L1 biosensor chips for the binding of the coagulation factor VIII.

D. Josić, M. Shima, E. Behre, 2001, Journal of chromatography. A.

Haemophilia A: effects of inhibitory antibodies on factor VIII functional interactions and approaches to prevent their action

M. Shima, E. Saenko, A. Khrenov, 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

Inhibitors in hemophilia A: mechanisms of inhibition, management and perspectives

S. Lacroix-Desmazes, C. Hauser, M. Shima, 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Receptor‐mediated clearance of factor VIII: implications for pharmacokinetic studies in individuals with haemophilia

E. Saenko, N. Ananyeva, 2006 .

Molecular basis of haemophilia A

J. Oldenburg, E. Saenko, N. Ananyeva, 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

Development of improved factor VIII molecules and new gene transfer approaches for hemophilia A.

R. Hawley, A. Ramezani, E. Saenko, 2003, Current gene therapy.

Mathematical models of blood coagulation and platelet adhesion: clinical applications.

M. Panteleev, F. Ataullakhanov, F I Ataullakhanov, 2007, Current pharmaceutical design.

Factor VIII – novel insights into form and function

E. Tuddenham, E. Saenko, G. Kemball-Cook, 2002, British journal of haematology.

Expression of factor VIII in recombinant and transgenic systems.

Charlotte A E Hauser, C. Hauser, S. Soukharev, 2002, Blood cells, molecules & diseases.

Cell Surface Heparan Sulfate Proteoglycans Participate in Factor VIII Catabolism Mediated by Low Density Lipoprotein Receptor-related Protein*

M. Shima, M Shima, E. Saenko, 2001, The Journal of Biological Chemistry.

Mutagenesis lowers factor VIII immunogenicity

D. Scott, N. Ananyeva, 2004 .

Mutagenesis lowers factor VIII immunogenicity Mutagenesis of an epitope within the A2 domain of fVIII not only reduces reactiv-ity with inhibitory antibodies, but also decreases in vivo immunogenicity of human fVIII in hemophilic mice.

N. Ananyeva, 2004 .

Molecular basis for different ability of low-density and high-density lipoproteins to support activity of the intrinsic Xase complex.

Djuro Josic, Horst Schwinn, D. Josić, 2002, Thrombosis research.

Studies on the histogenesis of myxomatous tissue of human coronary lesions.

M. Leon, M. Hong, C. Haudenschild, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Oxidized LDL mediates the release of fibroblast growth factor-1.

J. Berliner, G. Chisolm, J. Winkles, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Monoclonal antibodies to dalargin--a synthetic analog of enkephalins.

N. Ananyeva, L. Yakubov, O. Rokhlin, 1988, Immunology Letters.

Spatial propagation and localization of blood coagulation are regulated by intrinsic and protein C pathways, respectively.

Mikhail A Panteleev, Fazoil I Ataullakhanov, Mikhail V Ovanesov, 2006, Biophysical journal.

Molecular modifications in factor VIII concentrates produced from different plasma pools.

Y. Lim, D. Josić, M. Shima, 2001, Thrombosis research.

Effect of factor VIII on tissue factor-initiated spatial clot growth

F. Ataullakhanov, M. Ovanesov, E. Saenko, 2003, Thrombosis and Haemostasis.